KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medtronic (MDT) Other Operating Expenses (2017 - 2026)

Medtronic (MDT) has disclosed Other Operating Expenses for 11 consecutive years, with -$35.0 million as the latest value for Q1 2026.

  • Quarterly Other Operating Expenses fell 800.0% to -$35.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$142.0 million through Jan 2026, up 67.65% year-over-year, with the annual reading at $23.0 million for FY2025, 104.96% up from the prior year.
  • Other Operating Expenses hit -$35.0 million in Q1 2026 for Medtronic, down from -$22.0 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $125.0 million in Q1 2023 to a low of -$477.0 million in Q2 2024.
  • Historically, Other Operating Expenses has averaged -$30.4 million across 5 years, with a median of -$15.0 million in 2025.
  • Biggest five-year swings in Other Operating Expenses: skyrocketed 561.9% in 2022 and later tumbled 6900.0% in 2025.
  • Year by year, Other Operating Expenses stood at $97.0 million in 2022, then tumbled by 68.04% to $31.0 million in 2023, then increased by 9.68% to $34.0 million in 2024, then plummeted by 164.71% to -$22.0 million in 2025, then plummeted by 59.09% to -$35.0 million in 2026.
  • Business Quant data shows Other Operating Expenses for MDT at -$35.0 million in Q1 2026, -$22.0 million in Q4 2025, and -$70.0 million in Q3 2025.